Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Grey Wolf Therapeutics Limited
Sponsor

Grey Wolf Therapeutics Limited

United Kingdom 99 Park Drive, Milton, OX14 4RY, United Kingdom

About the sponsor

Grey Wolf Therapeutics Limited is active in research for solid malignancies, with a focus on antineoplastic therapy and treatment approaches for advanced cancer.

  • Advanced malignancies
  • Combination cancer therapy
  • Immune checkpoint inhibitor combinations

The sponsor’s oncology portfolio reflects interest in therapies designed to address difficult-to-treat malignant disease and support new treatment options in oncology.

About Specializations

Grey Wolf Therapeutics Limited runs clinical trials in conditions such as Neoplasm malignant, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

1 clinical trial

Neoplasm malignant

Not recruiting
Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Cemiplimab
  • Sponsor:Grey Wolf Therapeutics Limited

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.